Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

115. Ariel I, Sughayer M, Fellig Y, Pizov G,
Ayesh S, Podeh D, Libdeh BA, Levy C,
Birman T, Tykocinski ML, de Groot N,
Hochberg A (2000). The imprinted H19
gene is a marker of early recurrence in
human bladder carcinoma. Mol Pathol 53:
320-323.
116. Arkovitz MS, Ginsburg HB, Eidelman
J, Greco MA, Rauson A (1996). Primary
extrarenal Wilms’ tumor in the inguinal
canal: case report and review of the literature.
J Pediatr Surg 31: 957-959.
117. Armas OA, Aprikian AG, Melamed J,
Cordon-Cardo C, Cohen DW, Erlandson R,
Fair WR, Reuter VE (1994). Clinical and
pathobiological effects of neoadjuvant
total androgen ablation therapy on clinically
localized prostatic adenocarcinoma.
Am J Surg Pathol 18: 979-991.
118. Armstrong GR, Buckley CH, Kelsey
AM (1991). Germ cell expression of placental
alkaline phosphatase in male
pseudohermaphroditism. Histopathology
18: 541-547.
119. Arrizabalaga M, Navarro J, Mora M,
Castro M, Extramiana J, Manas A, Diez J,
Paniagua P (1994). [Transitional carcinomas
of the urinary tract: synchronous and
metachronous lesions]. Actas Urol Esp 18:
782-796.
120. Arroyo MR, Green DM, Perlman EJ,
Beckwith JB, Argani P (2001). The spectrum
of metanephric adenofibroma and
related lesions: clinicopathologic study of
25 cases from the National Wilms Tumor
Study Group Pathology Center. Am J Surg
Pathol 25: 433-444.
121. Artandi SE, Chang S, Lee SL, Alson S,
Gottlieb GJ, Chin L, Depinho RA (2000).
Telomere dysfunction promotes nonreciprocal
translocations and epithelial
cancers in mice. Nature 406: 641-645.
122. Arya M, Hayne D, Brown RS,
O’Donnell PJ, Mundy AR (2001).
Hemangiopericytoma of the seminal vesicle
presenting with hypoglycemia. J Urol
166: 992.
123. Asakura H, Nakazono M, Masuda T,
Yamamoto T, Tazaki H (1989). [Priapism
with malignant lymphoma: a case report].
Hinyokika Kiyo 35: 1811-1814.
124. Ascoli V, Facciolo F, Rahimi S, Scalzo
CC, Nardi F (1996). Concomitant malignant
mesothelioma of the pleura, peritoneum,
and tunica vaginalis testis. Diagn
Cytopathol 14: 243-248.
125. Ashfaq R, Weinberg AG, Albores-
Saavedra J (1993). Renal angiomyolipomas
and HMB-45 reactivity. Cancer 71:
3091-3097.
126. Assaf G, Mosbah A, Homsy Y,
Michaud J (1983). Dermoid cyst of testis in
five-year-old-child. Urology 22: 432-434.
127. Atalay AC, Karaman MI, Basak T,
Utkan G, Ergenekon E (1998). Non-
Hodgkin’s lymphoma of the female urethra
presenting as a caruncle. Int Urol Nephrol
30: 609-610.
128. Atiyeh BA, Barakat AJ, Abumrad NN
(1997). Extra-adrenal pheochromocytoma.
J Nephrol 10: 25-29.
129. Atkin NB, Baker MC (1982). Specific
chromosome change, i(12p), in testicular
tumours? Lancet 2: 1349.
130. Atkin NB, Baker MC (1983). i(12p):
specific chromosomal marker in seminoma
and malignant teratoma of the testis?
Cancer Genet Cytogenet 10: 199-204.
131. Atkin NB, Baker MC (1985). Cytogenetic
study of ten carcinomas of the bladder:
involvement of chromosomes 1 and 11.
Cancer Genet Cytogenet 15: 253-268.
132. Atkin NB, Baker MC (1991). Numerical
chromosome changes in 165 malignant
tumors. Evidence for a nonrandom distribution
of normal chromosomes. Cancer Genet
Cytogenet 52: 113-121.
133. Atkin NB, Baker MC, Wilson GD (1995).
Chromosome abnormalities and p53
expression in a small cell carcinoma of the
bladder. Cancer Genet Cytogenet 79: 111-
114.
134. Atkin NB, Fox MF (1990). 5q deletion.
The sole chromosome change in a carcinoma
of the bladder. Cancer Genet Cytogenet
46: 129-131.
135. Attanoos RL, Gibbs AR (2000). Primary
malignant gonadal mesotheliomas and
asbestos. Histopathology 37: 150-159.
136. Atuk NO, Stolle C, Owen JA, Carpenter
JT, Vance ML (1998). Pheochromocytoma
in von Hippel-Lindau disease: clinical presentation
and mutation analysis in a large,
multigenerational kindred. J Clin Endocrinol
Metab 83: 117-120.
137. Au WY, Shek WH, Nicholls J, Tse KM,
Todd D, Kwong YL (1997). T-cell intravascular
lymphomatosis (angiotropic large cell
lymphoma): association with Epstein-Barr
viral infection. Histopathology 31: 563-567.
138. Aubert J, Casamayou J, Denis P,
Hoppler A, Payen J (1978). Intrarenal teratoma
in a newborn child. Eur Urol 4: 306-
308.
139. Aus G, Bergdahl S, Frosing R, Lodding
P, Pileblad E, Hugosson J (1996). Reference
range of prostate-specific antigen after
transurethral resection of the prostate.
Urology 47: 529-531.
140. Avery AK, Beckstead J, Renshaw AA,
Corless CL (2000). Use of antibodies to RCC
and CD10 in the differential diagnosis of
renal neoplasms. Am J Surg Pathol 24: 203-
210.
141. Aveyard JS, Skilleter A, Habuchi T,
Knowles MA (1999). Somatic mutation of
PTEN in bladder carcinoma. Br J Cancer
80: 904-908.
142. Axelrod HR, Gilman SC, D’Aleo CJ,
Petrylak D, Reuter V, Gulfo JV, Saad A,
Cordon-Cardo C, Scher HI (1992).
Preclinical results and human immunohistochemical
studies with 90y-CYT-366: a
new prostate cancer therapeutic agent. J
Urol 147: 361A.
143. Ayala AG, Ro JY, Babaian R, Troncoso
P, Grignon DJ (1989). The prostatic capsule:
does it exist? Its importance in the staging
and treatment of prostatic carcinoma. Am J
Surg Pathol 13: 21-27.
144. Azzopardi JD, Mostofi FK, Theiss EA
(1961). Lesions of testes observed in certain
patients with widespread choriocarcinoma
and related tumors; the significance and
genesis of henatoxylin-staining bodies in
human testes. Am J Pathol 38: 207-225.
145. Azzopardi JG, Hoffbrand AV (1965).
Retrogression in testicular seminoma with
viable metastases. J Clin Pathol 18: 135-141.
146. Babaian RJ, Johnson DE (1980).
Primary carcinoma of the ureter. J Urol 123:
357-359.
147. Babaian RJ, Sayer J, Podoloff DA,
Steelhammer LC, Bhadkamkar VA, Gulfo JV
(1994). Radioimmunoscintigraphy of pelvic
lymph nodes with 111indium-labeled monoclonal
antibody CYT-356. J Urol 152: 1952-
1955.
148. Babu VR, Lutz MD, Miles BJ, Farah RN,
Weiss L, van Dyke DL (1987). Tumor behavior
in transitional cell carcinoma of the
bladder in relation to chromosomal markers
and histopathology. Cancer Res 47:
6800-6805.
149. Badawi AF, Cooper DP, Mostafa MH,
Aboul-Azm T, Barnard R, Margison GP,
O’Connor PJ (1994). O6-alkylguanine-DNA
alkyltransferase activity in schistosomiasisassociated
human bladder cancer. Eur J
Cancer 30A: 1314-1319.
150. Badawi AF, Mostafa MH, Aboul-Azm T,
Haboubi NY, O’Connor PJ, Cooper DP
(1992). Promutagenic methylation damage
in bladder DNA from patients with bladder
cancer associated with schistosomiasis
and from normal individuals.
Carcinogenesis 13: 877-881.
151. Badcock G, Pigott C, Goepel J,
Andrews PW (1999). The human embryonal
carcinoma marker antigen TRA-1-60 is a
sialylated keratan sulfate proteoglycan.
Cancer Res 59: 4715-4719.
152. Badoual C, Tissier F, Lagorce-Pages C,
Delcourt A, Vieillefond A (2002). Pulmonary
metastases from a chromophobe renal cell
carcinoma: 10 years’ evolution.
Histopathology 40: 300-302.
153. Baer SC, Ro JY, Ordonez NG, Maiese
RL, Loose JH, Grignon DJ, Ayala AG (1993).
Sarcomatoid collecting duct carcinoma: a
clinicopathologic and immunohistochemical
study of five cases. Hum Pathol 24: 1017-
1022.
154. Bagg MD, Wettlaufer JN, Willadsen
DS, Ho V, Lane D, Thrasher JB (1994).
Granulocytic sarcoma presenting as a diffuse
renal mass before hematological manifestations
of acute myelogenous leukemia.
J Urol 152: 2092-2093.
155. Bahn DK, Brown RK, Shei KY, White DB
(1990). Sonographic findings of leiomyoma
in the seminal vesicle. J Clin Ultrasound 18:
517-519.
156. Bahnson RR, Dresner SM, Gooding W,
Becich MJ (1989). Incidence and prognostic
significance of lymphatic and vascular invasion
in radical prostatectomy specimens.
Prostate 15: 149-155.
157. Bailey D, Baumal R, Law J, Sheldon K,
Kannampuzha P, Stratis M, Kahn H, Marks
A (1986). Production of a monoclonal antibody
specific for seminomas and dysgerminomas.
Proc Natl Acad Sci USA 83: 5291-
5295.
158. Bain GO, Danyluk JM, Shnitka TK,
Jewell LD, Manickavel V (1985). Malignant
fibrous histiocytoma of prostate gland.
Urology 26: 89-91.
159. Bainbridge TC, Singh RR, Mentzel T,
Katenkamp D (1997). Solitary fibrous tumor
of urinary bladder: report of two cases. Hum
Pathol 28: 1204-1206.
160. Baisden BL, Kahane H, Epstein JI
(1999). Perineural invasion, mucinous fibroplasia,
and glomerulations: diagnostic features
of limited cancer on prostate needle
biopsy. Am J Surg Pathol 23: 918-924.
161. Baker JM, Murty VV, Potla L, Mendola
CE, Rodriguez E, Reuter VE, Bosl GG,
Chaganti RS (1994). Loss of heterozygosity
and decreased expression of NME genes
correlate with teratomatous differentiation
in human male germ cell tumors. Biochem
Biophys Res Commun 202: 1096-1103.
162. Bala S, Oliver H, Renault B,
Montgomery K, Dutta S, Rao P, Houldsworth
J, Kucherlapati R, Wang X, Chaganti RS,
Murty VV (2000). Genetic analysis of the
APAF1 gene in male germ cell tumors.
Genes Chromosomes Cancer 28: 258-268.
163. Balaji KC, McGuire M, Grotas J,
Grimaldi G, Russo P (1999). Upper tract
recurrences following radical cystectomy:
an analysis of prognostic factors, recurrence
pattern and stage at presentation. J
Urol 162: 1603-1606.
164. Ballotta MR, Borghi L, Barucchello G
(2000). Adenocarcinoma of the rete testis.
Report of two cases. Adv Clin Path 4: 169-
173.
165. Balsitis M, Sokol M (1990). Ossifying
malignant Leydig (interstitial) cell tumour of
the testis. Histopathology 16: 597-601.
166. Banks ER, Mills SE (1990). Histiocytoid
(epithelioid) hemangioma of the testis. The
so-called vascular variant of “adenomatoid
tumor”. Am J Surg Pathol 14: 584-589.
167. Bar W, Hedinger C (1976). Comparison
of histologic types of primary testicular germ
cell tumors with their metastases: consequences
for the WHO and the British
Nomenclatures? Virchows Arch A Pathol
Anat Histol 370: 41-54.
168. Barentsz JO, Jager GJ, Witjes JA, Ruijs
JH (1996). Primary staging of urinary bladder
carcinoma: the role of MRI and a comparison
with CT. Eur Radiol 6: 129-133.
169. Barker KT, Bevan S, Wang R, Lu YJ,
Flanagan AM, Bridge JA, Fisher C, Finlayson
CJ, Shipley J, Houlston RS (2002). Low frequency
of somatic mutations in the FH/multiple
cutaneous leiomyomatosis gene in sporadic
leiomyosarcomas and uterine
leiomyomas. Br J Cancer 87: 446-448.
170. Barocas DA, Han M, Epstein JI, Chan
DY, Trock BJ, Walsh PC, Partin AW (2001).
Does capsular incision at radical retropubic
prostatectomy affect disease-free survival
in otherwise organ-confined prostate cancer?
Urology 58: 746-751.
171. Barreto J, Caballero C, Cubilla AL (1997).
Penis. In: Histology for Pathologists, SS
Sternberg, ed. Lippincott Raven Press: New
York.
172. Barsky SH (1987). Germ cell tumors of
the testis. In: Surgical Pathology of Urologic
Diseases, N Javadpour, SH Barsky, eds.
Williams and Wilkins: Baltimore, pp. 224-246.
173. Bartel F, Taubert H, Harris LC (2002).
Alternative and aberrant splicing of MDM2
mRNA in human cancer. Cancer Cell 2: 9-15.
174. Bartkova J, Rajpert-de Meyts E,
Skakkebaek NE, Bartek J (1999). D-type
cyclins in adult human testis and testicular
cancer: relation to cell type, proliferation,
differentiation, and malignancy. J Pathol
187: 573-581.
175. Bartkova J, Thullberg M, Rajpert-de
Meyts E, Skakkebaek NE, Bartek J (2000).
Cell cycle regulators in testicular cancer:
loss of p18INK4C marks progression from
carcinoma in situ to invasive germ cell
tumours. Int J Cancer 85: 370-375.
176. Bartkova J, Thullberg M, Rajpert-de
Meyts E, Skakkebaek NE, Bartek J (2000).
Lack of p19INK4d in human testicular germcell
tumours contrasts with high expression
during normal spermatogenesis. Oncogene
19: 4146-4150.
177. Baschinsky DY, Niemann TH, Maximo
CB, Bahnson RR (1998). Seminal vesicle cystadenoma:
a case report and literature
review. Urology 51: 840-845.
178. Baserga R (2000). The contradictions of
the insulin-like growth factor 1 receptor.
Oncogene 19: 5574-5581.
179. Bassler TJJr, Orozco R, Bassler IC,
Boyle LM, Bormes T (1999). Adenosquamous
carcinoma of the prostate: case
report with DNA analysis, immunohistochemistry,
and literature review. Urology 53:
832-834.
180. Bastacky SI, Walsh PC, Epstein JI
(1993). Relationship between perineural
tumor invasion on needle biopsy and radical
prostatectomy capsular penetration in clinical
stage B adenocarcinoma of the prostate.
Am J Surg Pathol 17: 336-341.
308 References